Skip Ribbon Commands
Skip to main content
 


SWOG S0931: EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study


Trial Focus

Kidney Cancer

Objective

         This study is being conducted to see whether treatment with everolimus after surgery for kidney cancer will increase the time without cancer returning.

IRB Protocol #

11-0545

Trial Status

OPEN

Principle Investigator

ELAINE LAM

Sponsor

SWOG

Contact

MARY ANDUHA at (720)848-0659 or MARY.ANDUHA@UCDENVER.EDU

Location

Dept Of Veterans Affairs Medical Center ST. MARYS HOSPITAL - G.J. University of Colorado Hospital Valley View Hospital Dept Of Veterans Affairs Medical Center ST. MARYS HOSPITAL - G.J. University of Colorado Hospital Valley View Hospital

Eligibility and Other Participant Information


What To Expect : A screening period will be conducted to determine eligibility. Treatment period can last up to 54 weeks. A follow up period will consist of clinic visits every six months for the first two years and then yearly thereafter until 10 years after registration. // Eligibility criteria include but are not limited to 18 years or older with cancer of the kidney.Eligibility criteria include but are not limited to 18 years or older with cancer of the kidney.